Department of Defense Awards $5.7M Contract to PharmAthene

by Eddie Staley, Benzinga Editor
August 16, 2011 9:02 AM | 15 seconds read |
PharmAthene, Inc. PIP announced today that the Company has been awarded a $5.7 million contract under a Department of Defense Broad Agency Announcement for studies directed at the development of an advanced expression system for the bioproduction of its nerve agent medical countermeasure program.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsContractsBiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!